Strides in Vaccine Development

09.13.13 | By

Despite some tremendous strides in vaccine development over the years, vaccines remain a major public health challenge for patients and their families throughout the world. This week we released our Medicines in Development: Vaccines report, which shows there are more than 270 vaccines in the pipeline to prevent and/or treat a wide array of diseases, including various forms of cancer and neurological disorders. 

Spotlight on PhRMA Research & Hope Awards

09.13.13 | By

WUSA 9 - TV highlighted the importance of vaccines and immunizations during a segment that aired on the evening news here in Washington last night.  The segment comes on the heels of PhRMA’s annual Research & Hope Awards ceremony celebrating individuals and teams in the medical innovation ecosystem who are contributing great

John J. Castellani Remarks: 2013 Research and Hope Awards

Health Care Reform in Turkey

09.13.13 | By

Turkey is at the vanguard of a global trend of implementing universal health coverage. Building on that leadership position, Prime Minister Erdoğan has set a goal for Turkey to become a global leader in the delivery of health services over the next decade. A key element of developing the health care market in Turkey is expanding the country’s biopharmaceutical sector.

Impact on Improving Public Health

09.11.13 | By

Today, PhRMA and its 2013 Research & Hope Awards partners are honoring visionaries in the vaccines and immunization field.

Vaccines are essential health resources

09.11.13 | By

To say that vaccines have changed the world for the better is a dramatic understatement. Vaccines have helped us to eradicate smallpox. They’ve helped to dramatically reduce the scourge of polio around the globe. They’ve prevented and controlled once deadly viruses like measles, rubella, influenzas and a host of other infectious and communicable conditions.  They are giving us new preventative and therapeutic tools to use in the fight against some cancers and other diseases.

U.S. Rep. Clyburn Explains How Clinical Trials Provide Opportunity to Address Health Disparities

09.10.13 | By

As you may know from a previous Catalyst post, late last month we unveiled a new report on Research in Your Backyard: Pharmaceutic

Team Hoyt Shares Hope

09.09.13 | By

I recently had the opportunity to speak to Team Hoyt, a father and son team, that have run over 1,000 endurance races together. Team Hoyt has been inducted into the Ironman Hall of fame,  honored with a life size bronze statue of their likeness by the start of the Boston marathon, and presented with the Jimmy V perseverance award.

Draft Guidance on Expedited Programs demonstrates FDA has broad regulatory flexibility to establish the safety and efficacy of innovative medicines to address unmet medical needs

09.09.13 | By

PhRMA has long supported the FDA’s appropriate use of innovative approaches and regulatory flexibility to establish the safety and efficacy of innovative medicines to address unmet medical needs.  We strongly supported the passage last year of the Food and Drug Administration Safety and Innovation Act (

Significance in Preventative Medicine

09.09.13 | By

Innovative research and development has led to revolutionary medical treatments and practices that have impacted how we think about preventative medicine. While colloquialisms like “an apple a day keeps the doctor away” still hold true, thanks to hardworking researchers, academics and individuals throughout the health care ecosystem, we now have an increasing selection of cutting-edge treatments that can protect us from some of the most debilitating diseases.

Pages

Subscribe to RSS - Opinion